Becton, Dickinson and Company (0R19.L)
USD 199.63
(-0.23%)
USD 199.63
(-0.23%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 3.27 Billion USD | 1.52% |
| 2022 | 3.22 Billion USD | 17.54% |
| 2021 | 2.74 Billion USD | 0.0% |
| 2020 | 2.74 Billion USD | 6.36% |
| 2019 | 2.57 Billion USD | 5.22% |
| 2018 | 2.45 Billion USD | 34.82% |
| 2017 | 1.81 Billion USD | 5.76% |
| 2016 | 1.71 Billion USD | -12.25% |
| 2015 | 1.95 Billion USD | 31.04% |
| 2014 | 1.49 Billion USD | 6.63% |
| 2013 | 1.4 Billion USD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 3.3 Billion USD | 0.95% |
| 2024 Q3 | 3.25 Billion USD | 0.81% |
| 2024 Q2 | 3.22 Billion USD | -2.27% |
| 2023 Q1 | 3.6 Billion USD | 11.79% |
| 2023 Q4 | 3.27 Billion USD | -8.78% |
| 2023 FY | 3.27 Billion USD | 1.52% |
| 2023 Q3 | 3.58 Billion USD | -1.86% |
| 2023 Q2 | 3.65 Billion USD | 1.44% |
| 2022 FY | 3.22 Billion USD | 17.54% |
| 2022 Q3 | 3.16 Billion USD | -2.92% |
| 2022 Q4 | 3.22 Billion USD | 1.93% |
| 2022 Q2 | 3.25 Billion USD | 7.35% |
| 2022 Q1 | 3.03 Billion USD | 5.9% |
| 2021 FY | 2.74 Billion USD | 0.0% |
| 2021 Q3 | 2.94 Billion USD | 1.8% |
| 2021 Q1 | 2.81 Billion USD | 2.62% |
| 2021 Q2 | 2.89 Billion USD | 2.84% |
| 2021 Q4 | 2.86 Billion USD | -2.75% |
| 2020 FY | 2.74 Billion USD | 6.36% |
| 2020 Q4 | 2.74 Billion USD | -6.89% |
| 2020 Q2 | 2.79 Billion USD | 1.23% |
| 2020 Q3 | 2.94 Billion USD | 5.44% |
| 2020 Q1 | 2.76 Billion USD | 7.02% |
| 2019 FY | 2.57 Billion USD | 5.22% |
| 2019 Q4 | 2.57 Billion USD | -1.9% |
| 2019 Q2 | 2.62 Billion USD | 4.2% |
| 2019 Q3 | 2.62 Billion USD | 0.04% |
| 2019 Q1 | 2.52 Billion USD | 2.9% |
| 2018 FY | 2.45 Billion USD | 34.82% |
| 2018 Q4 | 2.45 Billion USD | -4.33% |
| 2018 Q3 | 2.56 Billion USD | 0.71% |
| 2018 Q2 | 2.54 Billion USD | -14.23% |
| 2018 Q1 | 2.96 Billion USD | 63.15% |
| 2017 Q1 | 1.69 Billion USD | -1.57% |
| 2017 Q2 | 1.74 Billion USD | 3.25% |
| 2017 Q3 | 1.82 Billion USD | 4.69% |
| 2017 Q4 | 1.81 Billion USD | -0.6% |
| 2017 FY | 1.81 Billion USD | 5.76% |
| 2016 Q1 | 1.98 Billion USD | 1.28% |
| 2016 FY | 1.71 Billion USD | -12.25% |
| 2016 Q4 | 1.71 Billion USD | -6.37% |
| 2016 Q3 | 1.83 Billion USD | -0.49% |
| 2016 Q2 | 1.84 Billion USD | -7.01% |
| 2015 Q2 | 2.27 Billion USD | 50.73% |
| 2015 Q1 | 1.51 Billion USD | 1.14% |
| 2015 Q3 | 2.01 Billion USD | -11.41% |
| 2015 Q4 | 1.95 Billion USD | -2.97% |
| 2015 FY | 1.95 Billion USD | 31.04% |
| 2014 Q1 | 1.46 Billion USD | 4.64% |
| 2014 FY | 1.49 Billion USD | 6.63% |
| 2014 Q2 | 1.51 Billion USD | 3.07% |
| 2014 Q3 | 1.55 Billion USD | 2.78% |
| 2014 Q4 | 1.49 Billion USD | -3.8% |
| 2013 Q2 | 1.39 Billion USD | 2.35% |
| 2013 Q3 | 1.4 Billion USD | 1.24% |
| 2013 Q4 | 1.4 Billion USD | -0.5% |
| 2013 Q1 | 1.35 Billion USD | 0.0% |
| 2013 FY | 1.4 Billion USD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Phreesia, Inc. | - USD | -Infinity% |
| Accuray Incorporated | 138.32 Million USD | -2266.184% |
| Align Technology, Inc. | 296.9 Million USD | -1002.384% |
| Elevance Health Inc. | -46.33 Billion USD | 107.064% |
| AxoGen, Inc. | 23.02 Million USD | -14118.071% |
| Boston Scientific Corporation | 2.48 Billion USD | -31.763% |
| CVS Health Corporation | 18.02 Billion USD | 81.842% |
| Cardinal Health, Inc. | 14.95 Billion USD | 78.117% |
| Centene Corporation | - USD | -Infinity% |
| DaVita Inc. | 143.1 Million USD | -2187.132% |
| HCA Healthcare, Inc. | 2.02 Billion USD | -61.95% |
| Hologic, Inc. | 679.8 Million USD | -381.465% |
| Humana Inc. | - USD | -Infinity% |
| IDEXX Laboratories, Inc. | 380.28 Million USD | -760.677% |
| Laboratory Corporation of America Holdings | 474.6 Million USD | -589.633% |
| Masimo Corporation | 545 Million USD | -500.55% |
| McKesson Corporation | 21.13 Billion USD | 84.517% |
| Patterson Companies, Inc. | 782.89 Million USD | -318.062% |
| Quest Diagnostics Incorporated | 190 Million USD | -1622.632% |
| ResMed Inc. | 822.25 Million USD | -298.054% |
| Henry Schein, Inc. | 1.81 Billion USD | -80.331% |
| Teladoc Health, Inc. | 29.51 Million USD | -10990.028% |
| Universal Health Services, Inc. | 216.98 Million USD | -1408.378% |
| Veeva Systems Inc. | - USD | -Infinity% |
| Baxter International Inc. | 2.82 Billion USD | -15.899% |
| Intuitive Surgical, Inc. | 1.22 Billion USD | -168.147% |
| Danaher Corporation | 2.59 Billion USD | -26.176% |
| Stryker Corporation | 4.84 Billion USD | 32.418% |
| Medtronic plc | 5.21 Billion USD | 37.263% |